These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22956446)

  • 21. Factors associated with the initiation of proton pump inhibitors in corticosteroid users.
    Munson JC; Wahl PM; Daniel G; Kimmel SE; Hennessy S
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):366-74. PubMed ID: 22278844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals.
    Maggio M; Lauretani F; Ceda GP; De Vita F; Bondi G; Corsonello A; Cattabiani C; Lattanzio F; Ruggiero C; Nouvenne A; Meschi T; Bandinelli S; Ferrucci L
    Bone; 2013 Dec; 57(2):437-42. PubMed ID: 24076021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proton pump inhibitors: impact of professional practice evaluation on prescriptions pertinence].
    Fuzier R; Maguès JP; Dupuis E; Pomiès S; Segui S; Sénard JM
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):814-8. PubMed ID: 21981846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.
    Hoedemaker NPG; Damman P; Ottervanger JP; Dambrink JHE; Gosselink ATM; Kedhi E; Kolkman E; de Winter RJ; van 't Hof AWJ
    Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):127-138. PubMed ID: 30084902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
    Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
    J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia.
    Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H
    BMJ Qual Saf; 2020 May; 29(5):365-373. PubMed ID: 31641029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
    Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
    J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton-pump inhibitor use and the development of new ischemic heart disease in non-cardiac chest pain patients.
    Kim Y; Ganocy S; Fass R
    Neurogastroenterol Motil; 2020 Jul; 32(7):e13844. PubMed ID: 32281192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
    Hatemi İ; Esatoğlu SN
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S57-S60. PubMed ID: 29199170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia.
    Roughead EE; Ramsay EN; Pratt NL; Ryan P; Gilbert AL
    Med J Aust; 2009 Feb; 190(3):114-6. PubMed ID: 19203305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
    Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
    Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
    Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
    Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining proton pump inhibitor prescription dispensing patterns and adherence to STOPP criteria for Nova Scotia Seniors Pharmacare Program beneficiaries.
    Carter JH; Sketris IS; Tamim H; Levy AR; Langley JM
    J Popul Ther Clin Pharmacol; 2019 Dec; 26(4):e37-e53. PubMed ID: 31909577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy.
    Lodato F; Poluzzi E; Raschi E; Piccinni C; Koci A; Olivelli V; Napoli C; Corvalli G; Nalon E; De Ponti F; Zoli M
    Eur J Intern Med; 2016 May; 30():31-36. PubMed ID: 26926561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk and Severity of Hospital-Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors.
    Lewis PO; Litchfield JM; Tharp JL; Garcia RM; Pourmorteza M; Reddy CM
    Pharmacotherapy; 2016 Sep; 36(9):986-93. PubMed ID: 27455386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The appropriateness of a proton pump inhibitor prescription.
    Moran N; Jones E; O'Toole A; Murray F
    Ir Med J; 2014; 107(10):326-7. PubMed ID: 25551900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.
    Johnstone J; Nerenberg K; Loeb M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.